d Pneumologie Herz-Kreislauf at IQVIA

Regensburg, Bavaria, Germany

Apply Now

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, Life SciencesIndustries

Requirements

Assertive personality and strong networker who can enthuse themselves and their contacts
Desire to make a difference as a pharmaceutical advisor
Strong communication skills
Willingness to work independently and in a results-oriented manner
Natural sciences degree, completed training as BTA/CTA/MTA or PTA, or certification as a qualified pharmaceutical representative

Responsibilities

Provide intensive support to selected doctors to promote the prescription of products and contribute significantly to company success
Successfully implement consulting strategies and convince key contacts
Develop innovative therapy concepts with conversation partners in demanding indications (for the benefit of patient health and well-being)

Skills

Pharmaceutical Sales

Medical Representative

Doctor Engagement

Prescription Promotion

Sales Strategies

Pneumology

Cardiology

Diabetes

COPD

Patient Therapy Concepts

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free